Your Page Title

Covaxin turns out to be the father of Covishield in giving trouble, 1 out of every 3 people is sick, weakening the flesh, bones and nerves.


The threat of the Coronavirus pandemic has undoubtedly reduced, but the serious side effects of the vaccines that were administered to prevent it are still coming to light. Recently there were reports of side effects of Covishield, now the news is that some serious side effects of Covaxin have also been reported.

Covaxin is a COVID-19 vaccine developed by the Indian company Bharat Biotech. times of India According to a news from India, a recently published study claimed that almost one-third i.e. one out of every three people taking Covaxin faced some problems within a year of getting the vaccine.

This research conducted by Banaras Hindu University (BHU) has been published in the journal ‘Drug Safety’. Let us know what is the whole issue.

Side effects of Covaxin

Indian scientists have reported that one-third of more than 900 people who have received Covaxin shots have seen a number of adverse effects, while about 50% of adolescents have been found to have upper respiratory tract infections.

  • Upper respiratory tract infections (such as the common cold)
  • new skin problems
  • Musculoskeletal disorders
  • hypothyroidism
  • eye problems

menstrual problems

menstrual problems

The same study also reported that about 5% of women taking Covaxin had menstrual problems.

skin disorders and headaches

skin disorders and headaches

The study reported that the common disorders of most people who got vaccinated were cured, but in many people, skin related disorders persisted even after 8.5 months. About 5% of adults and adolescents reported continuing headaches after 9 months.

Covishield also has many side effects

Covishield also has many side effects

It is noteworthy that this study has come out at a time when the pharmaceutical company AstraZeneca has admitted that their Covid-19 vaccine technology, which has been used by the Serum Institute of India in India to make the Covishield vaccine, may, in very few cases, Can cause blood clotting and reduced platelet count. This condition is also called ‘thrombosis with thrombocytopenia syndrome (TTS).’

How was the study done?

How was the study done?

Covaxin was the second most used Covid-19 vaccine in India after Covishield. The study reported that researchers included 926 people from the Institute of Medical Sciences. All these people had taken Covaxin. Researchers asked these people about long-term “particularly significant adverse events (AESIs)” that occurred a year after vaccination. According to the study, about 48% of adolescents and 43% of adults suffered from viral upper respiratory tract infection.

To read this story in English click here

Disclaimer: This article is for general information only. It cannot in any way be a substitute for any medicine or treatment. Always consult your doctor for more information.

Share on:

Leave a Comment